Pearl River Capital’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,259	Closed	-$250K	–	425
2024 Q1	$250K	Buy	+4,259	New	+$250K	0.04%	417
2023 Q1	–	Sell	-4,208	Closed	-$218K	–	488
2022 Q4	$218K	Buy	4,208 +297	+8%	+$15.4K	0.04%	465
2022 Q3	$267K	Buy	+3,911	New	+$267K	0.05%	392